Anita Marton
Anita Marton publishes mostly in Immunology, Cardiology and Cardiovascular Medicine and Oncology, on topics such as PARP inhibition in cancer therapy, Adenosine and Purinergic Signaling and Neutrophil, Myeloperoxidase and Oxidative Mechanisms.
- World rank
- #1,108,429 of 7,710,434 ranked researchers
- Rank in United States
- #358,367 of 1,627,098
- Works
- 21
- Citations
- 2.4k
- Citations per work
- 113.5
What does Anita Marton research?
Anita Marton's work is mostly in Medicine (23%), Biochemistry, Genetics and Molecular Biology (20%), Immunology and Microbiology (17%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences836.7%
- Everything else836.6%
- Health Sciences523.4%
- Medicine523.4%
- Physical Sciences13.3%
- Chemistry13.3%
- 1Immunology17% of their works
- 2Cardiology and Cardiovascular Medicine12% of their works
- 3Oncology12% of their works
- 4Physiology12% of their works
- 5Molecular Biology8% of their works
- 6Organic Chemistry3% of their works
Research topics
- PARP inhibition in cancer therapy
- Adenosine and Purinergic Signaling
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Cardiac electrophysiology and arrhythmias
- Advanced Glycation End Products research
- Cancer therapeutics and mechanisms
- Calcium signaling and nucleotide metabolism
- Immune Cell Function and Interaction
Which keywords describe Anita Marton's research?
The keywords of their largest research topics: Inflammation, BRCA Mutation, PARP Inhibitors, Adenosine Receptors, Purinergic Signalling, Arrhythmias, Long-QT Syndrome and Neutrophil Extracellular Traps.
- Topoisomerases
- NK Cell Recognition
- HMGB1
- Advanced Glycation End Products
- Neutrophil Extracellular Traps
- Arrhythmias
- Adenosine Receptors
- BRCA Mutation
- Inflammation
- PARP Inhibitors
- Purinergic Signalling
- Long-QT Syndrome
- Reactive Oxygen Species
- DNA
- Lysosomal Calcium Signaling
- Natural Killer Cells
- Two-pore Channels
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Inflammation103 topics
- BRCA Mutation71 topic
- PARP Inhibitors71 topic
- Adenosine Receptors51 topic
- Purinergic Signalling51 topic
- Arrhythmias31 topic
- Long-QT Syndrome31 topic
- Neutrophil Extracellular Traps31 topic
- Reactive Oxygen Species31 topic
- Advanced Glycation End Products21 topic
- DNA21 topic
- HMGB121 topic
- Lysosomal Calcium Signaling21 topic
- NK Cell Recognition21 topic
- Natural Killer Cells21 topic
- Topoisomerases21 topic
- Two-pore Channels21 topic
Where does Anita Marton work?
Anita Marton's main affiliation in the publication record is Inotek Pharmaceuticals (United States), United States.
How many publications and citations does Anita Marton have?
OpenAlex counts 21 works and 2,383 citations for Anita Marton, an h-index of 15, ranking #1,108,429 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Anita Marton. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.